in this issue
People & Business :: Earnings/Finance
Bayer reports higher sales and profits; ups pharma pipeline estimate
6:00 AM MST | February 28, 2014 | Natasha Alperowicz in Leverkusen
Bayer today reported higher sales and profits for the fourth quarter and full-year 2013 and gave a forecast for this year hoping to grow sales by about 5% on a currency- and portfolio-adjusted basis. Marijn Dekkers, chairman of Bayer, speaking at a press briefing in Leverkusen, said that the company’s five recently launched pharmaceutical products have a much higher peak sales potential than originally estimated. Meanwhile, Werner Baumann, CFO in response to a question on why Bayer continues to own Bayer MaterialScience (BMS), a business that does not have...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be: